JAMEEA WARD: Open Payments
NPI 1427721703 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 23 payments from 8 companies in 2025. Trend: 2023 $299 · 2024 $718 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 5 | $123 |
| Novo Nordisk Inc | 5 | $114 |
| Amgen Inc. | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Cumberland Pharmaceuticals, Inc. | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Cologuard Collection Kit, Ozempic, Rybelsus, OTEZLA, FARXIGA, JARDIANCE, KRISTALOSE, Kerendia.
Industry payments across TX — which companies pay providers there.
